EUVIMEDEUVIMED entdecken
Crossref

Practical recommendations for revaccination following BCMA-targeted therapies in adult patients with autoimmune diseases

Kevin L Winthrop, Leonard Calabrese, Cliff Bingham, Xavier Mariette, Charlie Zhou, Neely Mozaffarian

Annals of the Rheumatic Diseases · 2026-10

DOI: 10.1016/j.ard.2026.09.014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of the Rheumatic Diseases, 2026-10. Verfasst von Kevin L Winthrop und 5 weiteren Autor:innen. Beteiligte Einrichtung: Oregon Health & Science University, Portland, OR, USA. Electronic address: winthrop@ohsu.edu. Die Arbeit nennt 64 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Oregon Health & Science University, Portland, OR, USA. Electronic address: winthrop@ohsu.edu.
  • Cleveland Clinic, Cleveland, OH, USA.
  • Johns Hopkins Medicine, Baltimore, MD, USA.
  • Assistance Publique Hôpital Bicêtre, Paris, France.
  • Ouro Medicines, South San Francisco, CA, USA.

Zitieren

APA

Winthrop, K. L., Calabrese, L., Bingham, C., Mariette, X., Zhou, C., & Mozaffarian, N. (2026). Practical recommendations for revaccination following BCMA-targeted therapies in adult patients with autoimmune diseases. Annals of the Rheumatic Diseases. https://doi.org/10.1016/j.ard.2026.09.014

Vancouver

Winthrop KL, Calabrese L, Bingham C, Mariette X, Zhou C, Mozaffarian N. Practical recommendations for revaccination following BCMA-targeted therapies in adult patients with autoimmune diseases. Annals of the Rheumatic Diseases. 2026. doi:10.1016/j.ard.2026.09.014

BibTeX
@article{Winthrop2026,
  author = {Winthrop, Kevin L and Calabrese, Leonard and Bingham, Cliff and Mariette, Xavier and Zhou, Charlie and Mozaffarian, Neely},
  title = {Practical recommendations for revaccination following BCMA-targeted therapies in adult patients with autoimmune diseases},
  journal = {Annals of the Rheumatic Diseases},
  year = {2026},
  doi = {10.1016/j.ard.2026.09.014}
}
Kostenlos starten →